1 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Behavioural Activation Therapy: new trials by email Literature Review of Behavioural Activation Therapy trials Research Report on Behavioural Activation Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Behavioural Activation Therapy and Ketamine for Treatment-Resistant Depression Ketamine (0.5 mg/kg), Behavioural Activation Therapy - Treatment Resistant Depression, Major Depressive Disorder (MDD) | Phase 2 / Phase 3 | Recruiting | The Royal's Institute of Mental Health Research | 60 | 2026-10-30 | 2026-11-09 |
Depressive Disorder, Major (1) · Depressive Disorder, Treatment-Resistant (1)
The Royal's Institute of Mental Health Research (1)
Canada (1)
Jeanne Talbot, MD, PhD (1) · Jennifer Phillips, PhD (1)